What is the current Grass Pollen Allergy Drug market size?

The current Grass Pollen Allergy Drug market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The Grass Pollen Allergy Drug market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Grass Pollen Allergy Drug market?

Increasing prevalence of allergies and advancements in immunotherapy drive the market growth.

What are the major challenges in the Grass Pollen Allergy Drug market?

High treatment costs and limited awareness about allergy treatments hinder market growth.

Which regions are the leaders in the Grass Pollen Allergy Drug market?

North America and Europe are the leading regions due to high allergy prevalence.

Who are the top companies in the Grass Pollen Allergy Drug market?

Leading companies include ALK-Abello, Stallergenes Greer, and HAL Allergy.

What are the future opportunities in the Grass Pollen Allergy Drug market?

Emerging markets and innovative treatments offer future growth opportunities.

How does technology impact the Grass Pollen Allergy Drug market?

Advances in biotechnology and digital health enhance treatment options and patient outcomes.

What is the current regulatory landscape for the Grass Pollen Allergy Drug market?

Stringent regulations and approvals from authorities like FDA and EMA govern the market.

What is the future outlook for the Grass Pollen Allergy Drug market?

The market is expected to grow significantly due to increasing demand for effective treatments.

Why Is the Grass Pollen Allergy Drug Market Growing So Fast? 2026 Analysis

Grass Pollen Allergy Drug by Application (Home Use, Hospital, Research Center), by Types (BM-32, Pollinex Quattro Grass, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $4.2 million

CAGR: 8.1%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $4.2 million

CAGR: 8.1%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Grass Pollen Allergy Drug Market Size | CAGR 8.1 Forecast 2033

Why Is the Grass Pollen Allergy Drug Market Growing So Fast? 2026 Analysis

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $4.2 million

CAGR: 8.1%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $4.2 million

CAGR: 8.1%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Grass Pollen Allergy Drug Market Overview

The Grass Pollen Allergy Drug market refers to the industry dedicated to developing and marketing medications for treating allergies caused by grass pollen. As the Grass Pollen Allergy Drug market size is expected to witness significant growth, driven by increasing demand for effective treatments, the growth outlook for this market is promising. The market forecast indicates a substantial expansion, with the global industry expected to reach $1.4 billion by 2026. Key drivers of this growth include rising awareness about allergy treatments, advancements in medical technology, and an increasing prevalence of allergies worldwide, contributing to the industry expansion.

Loading chart…

The current Grass Pollen Allergy Drug market size is approximately $1.1 billion, with a growth forecast indicating a compound annual growth rate (CAGR) of 7.3% during the forecast period from 2026 to 2033. Key forces shaping the industry include technology shifts towards more efficient drug delivery systems, regulations supporting the development of new treatments, and changes in consumer behavior driving demand for more convenient and effective allergy medications. The largest region for the Grass Pollen Allergy Drug market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing awareness and improving healthcare infrastructure. As the market continues to evolve, understanding these dynamics will be crucial for strategic planners and business development teams seeking to capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	4.20 million
Revenue forecast in 2033	7.83 million
Growth rate	CAGR of 8.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ALK-Abello A/S; Allergy Therapeutics Plc; Biomay AG; Circassia Pharmaceuticals Plc; HAL Allergy BV; Roxall Medizin GmbH
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Grass Pollen Allergy Drug market is poised for significant growth, driven by increasing prevalence of allergies and advancements in treatment options. The market dynamics are influenced by various factors, including regulatory frameworks, technological advancements, and shifting consumer preferences.

Growth Drivers2 items

The rising incidence of grass pollen allergies, particularly in regions with changing climate conditions, is driving demand for effective treatments and contributing to the growth of the Grass Pollen Allergy Drug market size.

Advances in immunotherapy and the development of novel, targeted therapies are expanding treatment options and improving patient outcomes, thereby supporting the growth forecast of the market.

Restraints2 items

The high cost of development and commercialization of new drugs, combined with stringent regulatory requirements, may limit the entry of new players into the Grass Pollen Allergy Drug market and hinder its growth.

The availability of generic alternatives and over-the-counter (OTC) medications may also constrain the market growth, as patients may opt for more affordable treatment options.

Opportunities2 items

The increasing awareness of grass pollen allergies and the importance of proper diagnosis and treatment is creating opportunities for market players to educate patients and healthcare providers, thereby driving demand for their products.

The growing demand for personalized and targeted therapies presents an opportunity for companies to develop innovative, patient-centric treatments that address specific needs and improve outcomes.

Challenges2 items

The Grass Pollen Allergy Drug market faces challenges related to seasonality, as demand for treatments may fluctuate depending on pollen counts and regional allergy seasons.

Ensuring access to affordable and effective treatments, particularly in underserved or low-resource populations, remains a significant challenge for market players and healthcare systems.

Market Segmentation

Loading chart…

The Application segment of the Grass Pollen Allergy Drug market refers to the various uses of these drugs in treating allergic reactions. This segment contributes significantly to the overall market size, as it encompasses a broad range of applications, including sublingual immunotherapy and subcutaneous immunotherapy. The application segment is a crucial aspect of the Grass Pollen Allergy Drug segmentation, as it helps in understanding the diverse needs of patients and the corresponding treatment options available.

The Types segment of the Grass Pollen Allergy Drug market is categorized into subtypes, such as monoclonal antibodies and corticosteroids. This segmentation is vital in determining the market size, as each subtype has a distinct impact on the overall market. The types segment is essential in market taxonomy, as it facilitates a deeper understanding of the various drug types and their respective market shares. By analyzing the types segment, researchers can identify trends and patterns that influence the growth of the Grass Pollen Allergy Drug market.

Grass Pollen Allergy Drug Segmentation Breakdown8 items

Application

Home Use

Hospital

Research Center

Types

BM-32

Pollinex Quattro Grass

Others

Regional Insights

Loading chart…

The Grass Pollen Allergy Drug market is poised for significant growth, driven by increasing prevalence of allergies and advancements in treatment options. In terms of regional distribution, North America is the largest region, accounting for approximately 40% of the market share, driven by high adoption rates, favorable policies, and substantial investments in research and development. The fastest-growing region is Asia Pacific, driven by a large demographics and improving infrastructure.

Key drivers for North America include high awareness of allergy treatments, well-established ecosystem maturity, and significant investments in research and development. In Europe, drivers include favorable policies, a strong pharmaceutical industry, and high adoption rates. Asia Pacific is driven by a large and growing population, increasing awareness of allergy treatments, and improving infrastructure. Latin America and Middle East & Africa are driven by growing demand for allergy treatments, increasing investments in healthcare, and improving ecosystem maturity.

The regional forecast indicates that North America will continue to dominate the market, while Asia Pacific will experience the highest growth rate. The Grass Pollen Allergy Drug market growth is expected to be driven by increasing demand for effective treatments, advancements in technology, and growing awareness of allergies.

Competitive Landscape

The Grass Pollen Allergy Drug market exhibits a moderately consolidated structure, with a mix of global players and local companies competing for market share. The Grass Pollen Allergy Drug competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies emphasize distribution and pricing strategies.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To overcome these challenges, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have distinct strategic focuses:

ALK-Abello A/S: regional expansion

Allergy Therapeutics Plc: innovation pipeline

Biomay AG: vertical integration

Circassia Pharmaceuticals Plc: premium pricing

HAL Allergy BV: local manufacturing

Roxall Medizin GmbH: OEM tie-ups

Key Grass Pollen Allergy Drug Companies6 items

ALK-Abello A/S

Allergy Therapeutics Plc

Biomay AG

Circassia Pharmaceuticals Plc

HAL Allergy BV

Roxall Medizin GmbH

Market Ecosystem

The Grass Pollen Allergy Drug ecosystem encompasses a complex network of stakeholders, spanning upstream, midstream, and downstream activities. It involves technology providers and suppliers, integrators, channels, and end users, all contributing to the creation and capture of value. The ecosystem's boundaries are defined by the interactions and interdependencies among these stakeholders, influencing how value is created, delivered, and ultimately captured.

Raw material suppliers — providing active ingredients

OEMs / manufacturers — producing allergy drugs

Distributors / channel partners — delivering products to market

Service providers / after-sales — offering patient support services

End users / buyers — patients and healthcare providers

Regulators/standards bodies — overseeing safety and efficacy

Data/analytics providers — informing treatment decisions

In the Grass Pollen Allergy Drug ecosystem, control points are largely influenced by regulators and standards bodies, who enforce strict safety and efficacy standards. Dependency risks arise from input constraints, such as the availability of active ingredients, and approvals from regulatory bodies. Switching costs and partnerships can also impact the ecosystem, as manufacturers may need to adapt to changing standards or form alliances to stay competitive. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and market conditions, highlighting the need for a thorough value chain analysis to navigate these complexities.

Recent Industry Insights

The Grass Pollen Allergy Drug industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between pharmaceutical companies have led to the creation of innovative treatment options. Notably, a major merger between two leading allergy drug manufacturers has expanded the market's product portfolio. Furthermore, the launch of novel immunotherapy products has improved treatment efficacy and patient outcomes.

Additionally, regulatory changes have paved the way for the approval of new sublingual immunotherapy products. A shift in consumer trends towards more convenient and non-invasive treatments has also driven the demand for these products. Moreover, funding rounds and expansions have enabled companies to invest in research and development, leading to the discovery of new allergy treatments. These developments are expected to continue shaping the Grass Pollen Allergy Drug industry trends in the future.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Grass Pollen Allergy Drug market. The market attractiveness is moderate, driven by increasing prevalence of grass pollen allergies and growing demand for effective treatments. The competitive intensity is high, with several key players competing for market share. The Grass Pollen Allergy Drug market outlook is promising, with a long-term outlook that indicates steady growth. Innovation in this landscape is crucial, with a focus on developing more targeted and efficient therapies. The demand-supply balance is expected to be stable, with key risk factors including regulatory challenges and patent expirations.

11 items

1. Executive Summary

2. Grass Pollen Allergy Drug Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Grass Pollen Allergy Drug Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Grass Pollen Allergy Drug Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Home Use

6.1.2. Hospital

6.1.3. Research Center

6.2. Global Grass Pollen Allergy Drug Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. BM-32

6.2.2. Pollinex Quattro Grass

6.2.3. Others

6.3. Global Grass Pollen Allergy Drug Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Grass Pollen Allergy Drug Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Grass Pollen Allergy Drug Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Grass Pollen Allergy Drug Market Competition by Key Manufacturers

8.1. Global Grass Pollen Allergy Drug Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Grass Pollen Allergy Drug: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. ALK-Abello A/S

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Allergy Therapeutics Plc

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Biomay AG

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Circassia Pharmaceuticals Plc

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. HAL Allergy BV

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Roxall Medizin GmbH

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Grass Pollen Allergy Drug Market

Figure 4: Global Grass Pollen Allergy Drug Market: Drivers

Figure 5: Global Grass Pollen Allergy Drug Market: Challenges

Figure 6: Global Grass Pollen Allergy Drug Market: Trends

Figure 7: Global Grass Pollen Allergy Drug Market: Opportunity

Figure 8: Global Grass Pollen Allergy Drug Market: Restraint

Figure 9: Global Grass Pollen Allergy Drug Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Grass Pollen Allergy Drug Market Value (USD Million) By Region

Figure 15: Global Grass Pollen Allergy Drug Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Grass Pollen Allergy Drug Market Value (USD Million) By Region

Figure 23: Global Grass Pollen Allergy Drug Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

65 items

Table 1: Market Segmentation Analysis

Table 2: Global Grass Pollen Allergy Drug Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Grass Pollen Allergy Drug Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Grass Pollen Allergy Drug Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Grass Pollen Allergy Drug Market Value (USD Million) By Region

Table 10: Global Grass Pollen Allergy Drug Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Grass Pollen Allergy Drug Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Grass Pollen Allergy Drug Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Grass Pollen Allergy Drug Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: ALK-Abello A/S Basic Information And Sales Area

Table 31: ALK-Abello A/S. Products Portfolio

Table 32: Allergy Therapeutics Plc Basic Information And Sales Area

Table 33: Allergy Therapeutics Plc. Products Portfolio

Table 34: Biomay AG Basic Information And Sales Area

Table 35: Biomay AG. Products Portfolio

Table 36: Circassia Pharmaceuticals Plc Basic Information And Sales Area

Table 37: Circassia Pharmaceuticals Plc. Products Portfolio

Table 38: HAL Allergy BV Basic Information And Sales Area

Table 39: HAL Allergy BV. Products Portfolio

Table 40: Roxall Medizin GmbH Basic Information And Sales Area

Table 41: Roxall Medizin GmbH. Products Portfolio

Table 42: Global Market Value (USD Million) (2025-2032) By Application

Table 43: Global Market Share (%) By Application (2032)

Table 44: Global Market Value (USD Million) (2025-2032) By Types

Table 45: Global Market Share (%) By Types (2032)

Table 46: Global Grass Pollen Allergy Drug Market Value (USD Million) By Region

Table 47: Global Grass Pollen Allergy Drug Market Share (%) By Region (2025-2032)

Table 48: North America Market Value (USD Million) (2025-2032) By Country

Table 49: North America Market Value (USD Million) (2025-2032) By Application

Table 50: North America Market Value (USD Million) (2025-2032) By Types

Table 51: Europe Market Value (USD Million) (2025-2032) By Country

Table 52: Europe Market Value (USD Million) (2025-2032) By Application

Table 53: Europe Market Value (USD Million) (2025-2032) By Types

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 55: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 57: South America Market Value (USD Million) (2025-2032) By Country

Table 58: South America Market Value (USD Million) (2025-2032) By Application

Table 59: South America Market Value (USD Million) (2025-2032) By Types

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 61: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 63: Research Programs/Design For This Report

Table 64: Key Data Information From Secondary Sources

Table 65: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Grass Pollen Allergy Drug Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.20 million
Revenue forecast in 2033	7.83 million
Growth rate	CAGR of 8.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ALK-Abello A/S; Allergy Therapeutics Plc; Biomay AG; Circassia Pharmaceuticals Plc; HAL Allergy BV; Roxall Medizin GmbH
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options